Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 533.50
Bid: 532.50
Ask: 534.00
Change: 6.00 (1.14%)
Spread: 1.50 (0.282%)
Open: 525.50
High: 541.00
Low: 525.50
Prev. Close: 527.50
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of offering of senior secured notes

17 May 2019 07:00

RNS Number : 3365Z
Drax Group PLC
17 May 2019
 

Drax Group plc17 May 2019

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO AUSTRALIA, CANADA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS RELEASE.

17 May 2019

DRAX GROUP PLC(Symbol: DRX)

Drax Finco plc made the below announcement on the Luxembourg Stock Exchange in respect of its £350,000,000 41/4% Senior Secured Fixed Rate Notes due 2022 and $300,000,000 65/8% Senior Secured Notes due 2025

***************

Completion of offering of senior secured notes due 2025

On 16 May 2019, Drax Group plc's ("Drax") indirect wholly owned subsidiary, Drax Finco plc, completed and settled its offering (the "Offering") of U.S. dollar denominated 65/8% senior secured notes due 2025 (the "Notes") in an aggregate principal amount of $200 million.

The Notes bear interest at an interest rate of 6.625 per cent. per annum and were issued at 101.5 per cent. of their nominal value. The Notes were issued under the indenture governing Drax Finco plc's outstanding $300 million aggregate principal amount of 65/8% senior secured notes due 2025. Cross-currency swaps have been put in place to 2023 in relation to the proceeds of the Offering, as a result of which the effective sterling-equivalent interest rate applying to this new debt is 4.74 per cent. per annum.

The proceeds of the Offering will be used to repay in part outstanding amounts drawn under the group's acquisition bank facility(1), to pay related fees and expenses of the Offering, including underwriting fees and commissions, professional fees and other associated transaction costs as well as applicable prepayment fees and accrued and unpaid interest to the date of repayment. Drax continues to expect to refinance the remainder of the acquisition bank facility during 2019.

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 1757 612 491

 

Media:

Drax External Communications: Matt Willey

+44 (0) 1757 612 285

 

Website: www.drax.com

 

Note

(1) Drax Corporate Limited drew £550 million under an acquisition bank facility on 2 January 2019 used to partially fund the acquisition of Scottish Power Generation for an initial net consideration of £687 million. The facility has a 12-month duration from 31 December 2018, with an additional seven-month extension option.

 

Cautionary Statement

 

This release is being issued pursuant to Rule 135c under the U.S. Securities Act of 1933, as amended (the "Securities Act") and is for information purposes only and does not constitute a prospectus or any offer to sell or the solicitation of an offer to buy any security in the United States of America or in any other jurisdiction. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the Securities Act. The Notes and related guarantees were offered in a private offering exempt from the registration requirements of the Securities Act and were accordingly offered only to (i) qualified institutional buyers pursuant to Rule 144A under the Securities Act and (ii) certain non-U.S. persons outside the United States in compliance with Regulation S under the Securities Act. No indebtedness incurred in connection with any other financing transactions will be registered under the Securities Act.

 

This communication is directed only at persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended (the "Order"), (ii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations, etc.") of the Order, (iii) are persons who are outside the United Kingdom, and (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). Any investment activity to which this communication relates will only be available to, and will only be engaged in with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

 

This announcement is not a public offering in the Grand Duchy of Luxembourg or an offer of securities to the public in any European Economic Area member state that has implemented Directive 2003/71/EC, and any amendments thereto (together with any applicable implementing measures in any member state, the "Prospectus Directive").

 

Manufacturer target market (MiFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the Notes are not available to retail investors in the European Economic Area.

 

Forward Looking Statements

 

This release includes forward-looking statements within the meaning of the securities laws of certain applicable jurisdictions. These forward-looking statements can be identified by the use of forward-looking terminology, including, but not limited to, terms such as "aim", "anticipate", "assume", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "outlook", "plan", "predict", "project", "should", "will" or "would" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include, but are not limited to, all statements other than statements of historical facts and include statements regarding Drax's intentions, beliefs or current expectations concerning, among other things, Drax's future financial conditions and performance, results of operations and liquidity, strategy, plans, objectives, prospects, growth, goals and targets, future developments in the markets in which Drax participate or are seeking to participate, and anticipated regulatory changes in the industry in which Drax operate. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Readers are cautioned that forward-looking statements are not guarantees of future performance and are based on numerous assumptions. Given these risks and uncertainties, readers should not rely on forward looking statements as a prediction of actual results.

 

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCAFMRTMBJBBAL
Date   Source Headline
29th Oct 20209:38 amRNSHolding(s) in Company
28th Oct 20208:30 amRNSNotice of Change to Director Details
23rd Oct 202010:13 amRNSHolding(s) in Company
21st Oct 20204:13 pmRNSPricing of offering of Senior Secured Notes
21st Oct 202010:26 amRNSHolding(s) in Company
19th Oct 20207:10 amRNSFixed income investor calls
15th Oct 20202:57 pmRNSHolding(s) in Company
15th Oct 20202:41 pmRNSHolding(s) in Company
14th Oct 20205:31 pmRNSHolding(s) in Company
14th Oct 20205:29 pmRNSHolding(s) in Company
14th Oct 20205:28 pmRNSHolding(s) in Company
5th Oct 20204:37 pmRNSBlock listing Interim Review - Sharesave Plan
5th Oct 20204:33 pmRNSBlock listing Interim Review - PSP
5th Oct 20204:24 pmRNSBlock listing Interim Review - Bonus Matching Plan
1st Oct 20202:46 pmRNSTotal Voting Rights
14th Sep 20202:04 pmRNSInfrastructure debt facility
1st Sep 20204:45 pmRNSTotal Voting Rights
28th Aug 20209:00 amRNSHolding(s) in Company
3rd Aug 20205:21 pmRNSTotal Voting Rights
31st Jul 202011:00 amRNSDirector/PDMR Shareholding
30th Jul 202010:48 amRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSHalf-year Report
21st Jul 202012:00 pmRNSNotice of Half Year 2020 Financial Results
17th Jul 20209:33 amRNSHolding(s) in Company
15th Jul 202010:39 amRNSHolding(s) in Company
9th Jul 20203:57 pmRNSHolding(s) in Company
7th Jul 20209:57 amRNSHolding(s) in Company
1st Jul 20202:26 pmRNSTotal Voting Rights
25th Jun 202010:57 amRNSHolding(s) in Company
23rd Jun 20202:34 pmRNSHolding(s) in Company
15th Jun 20202:21 pmRNSHolding(s) in Company
12th Jun 202011:54 amRNSHolding(s) in Company
12th Jun 20207:00 amRNS£125 million ESG facility extended to 2025
9th Jun 20203:15 pmRNSDisclosure of rights attached to equity securities
3rd Jun 20204:01 pmRNSHolding(s) in Company
1st Jun 202010:43 amRNSTotal Voting Rights
27th May 20202:30 pmRNSDirector/PDMR Shareholding
15th May 20203:00 pmRNSDirector/PDMR Shareholding
14th May 20209:00 amRNSHolding(s) in Company
11th May 20208:45 amRNSHolding(s) in Company
11th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20209:00 amRNSTotal Voting Rights
27th Apr 20209:37 amRNSHolding(s) in Company
22nd Apr 202012:45 pmRNSResult of AGM
22nd Apr 20209:00 amRNSHolding(s) in Company
22nd Apr 20207:00 amRNSTrading Update
17th Apr 20209:00 amRNSDirector/PDMR Shareholding
15th Apr 20207:06 amRNSNotice of AGM
9th Apr 20204:28 pmRNSAdditional Listing
8th Apr 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.